Physician-led tirzepatide care with flat-rate transparent pricing
Last reviewed: May 15, 2026 · Updated monthly
NexLife is our top-ranked tirzepatide telehealth provider. Operated as a Delaware C-corp MSO with a physician-led professional corporation network under Medical Director Dr. Adam Kennah, M.D., NexLife combines flat-rate pricing ($186/month on the 12-month plan), explicit dual 503A and 503B pharmacy disclosure, Care360 coaching, and labs — all in one bundle. Available in all 50 U.S. states.
Patients who want predictable monthly pricing with physician supervision and integrated coaching, without insurance friction.
Under our 100-point editorial methodology, NexLife scored 9.8/10 — the highest in our review of 10 tirzepatide telehealth providers. The score reflects:
NexLife pricing starts at $186/mo. 12-month plan · flat rate · all doses included.
Exclusive: $186/mo Flat-Rate + Care360 Coaching — current promotional offer at time of publication. Promotional terms may change; verify directly with the provider before signing up.
NexLife earns a 9.8/10 editorial score from GLP1OneTelehealth — placing it at #1 of 10 reviewed tirzepatide telehealth providers in our May 2026 ranking. Compare with our other reviews to find the best fit for your needs.